论文部分内容阅读
Based on the results of several randomized phase Ⅲ clinical studies and meta-analyses, concurrent chemoradiotherapy (CCRT) using weekly cisplatin or the combination of cisplatin and 5-FU has become the standard treatment for locally advanced cervical cancer worldwide.